Keyphrases
Fabry Disease
100%
Arrhythmia
37%
Infantile Cardiomyopathy
29%
Ventricular Arrhythmia
28%
Atrial Fibrillation
28%
Transthoracic Echocardiography
28%
Heart Failure
28%
Pathophysiology
28%
Risk Prediction
27%
Cardiomyopathy
25%
Opioid Antagonist
25%
Permanent Pacemaker Implantation
25%
PhenoAge
25%
Clinical Risk
25%
Naltrexone
25%
Bradycardia
25%
Autism Spectrum Conditions
25%
Incidence Risk
25%
Cardiomyocyte Model
25%
Longitudinal Change
25%
Clinical Utilization
25%
Implantable Loop Recorder
25%
Accelerated Aging
25%
Snapshot Study
25%
Cardiovascular Phenotype
25%
Arrhythmogenesis
25%
ALMS1
25%
Alström Syndrome
25%
Human Induced Pluripotent Stem Cell-derived Cardiomyocytes (hiPSC-CMs)
25%
Novel Therapeutics
25%
Heart Arrhythmia
20%
Echocardiography
18%
β-endorphin
16%
Intellectual Disability
16%
Childhood Autism
16%
Inclusion Criteria
16%
Hyperactivity
16%
Chronological Age
15%
Glycosphingolipids
13%
Lysosomal Storage Disease
12%
Left Ventricular Hypertrophy
11%
Arrhythmogenic Substrate
10%
Multiple Organ Dysfunction
10%
Left Ventricular Size
10%
End-diastole
10%
Risk Stratification
9%
β-Galactosidase (β-Gal)
9%
Renal Disease
9%
Global Longitudinal Strain
9%
X-linked
8%
Medicine and Dentistry
Fabry Disease
75%
Systematic Review
50%
Diseases
49%
Myocardial Disease
48%
Cardiovascular System
37%
Echocardiography
33%
Accelerated Aging
25%
Implantable Loop Recorder
25%
Alstrom Syndrome
25%
Opiate Antagonist
25%
Autism Spectrum
25%
Naltrexone
25%
Hyperactivity
25%
Transthoracic Echocardiography
25%
Autism
25%
Permanent Pacemaker
25%
Pacemaker Implantation
25%
Atrial Fibrillation
25%
Pathophysiology
25%
Cardiac Muscle Cell
25%
Induced Pluripotent Stem Cell
25%
Cardiovascular Disease
21%
Cardiac Dysrhythmia
19%
Isotopes of Calcium
15%
Nephropathy
12%
Glycosphingolipid
9%
Restrictive Cardiomyopathy
9%
Galactosidase
8%
Lysosomal Storage Disease
8%
Premature Aging
8%
Placebo
8%
Restlessness
8%
Beta-Endorphin
8%
Pervasive Developmental Disorder
8%
Crying
8%
Clinical Trial
8%
Health Service
8%
Insulin Resistance
8%
Systolic Function
8%
Randomized Controlled Trial
8%
Endorphin
8%
Dyslipidemia
8%
Side Effect
8%
Stereotypy
8%
Opiate
8%
Irritability
8%
Orphan Disorder
8%
Maturation
8%
Left Ventricular Hypertrophy
6%
Electrocardiography
6%
Pharmacology, Toxicology and Pharmaceutical Science
Fabry Disease
100%
Heart Arrhythmia
70%
Myocardial Disease
32%
Congestive Heart Failure
28%
Atrial Fibrillation
27%
Pathophysiology
27%
Arrhythmogenesis
25%
Naltrexone
25%
Narcotic Antagonist
25%
Hyperactivity
25%
Alstrom Syndrome
25%
Diseases
19%
Intellectual Impairment
16%
Glycosphingolipid
12%
Lysosome Storage Disease
12%
Heart Left Ventricle Hypertrophy
9%
Storage Disease
8%
Clinical Trial
8%
Restlessness
8%
Randomized Controlled Trial
8%
Placebo
8%
Beta Endorphin
8%
Endorphin
8%
Opiate
8%
Side Effect
8%
Cardiovascular Disease
8%
Sphingolipid
6%
Galactosidase
6%
Inflammation
6%
Globotriaosylceramide
5%
